Bernard Vidalinc
Overview
Explore the profile of Bernard Vidalinc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goisnard A, Daumar P, Dubois C, Aubel C, Roux M, Depresle M, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439204
P-gp is the most widely studied MDR protein conferring cellular resistance to many standard or targeted therapeutic agents. For this reason, P-gp chemoresistance evaluation, established before or during chemotherapy, can...
2.
Goisnard A, Dubois C, Daumar P, Aubel C, Depresle M, Gauthier J, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33919619
Cancer spheroids are very effective preclinical models to improve anticancer drug screening. In order to optimize and extend the use of spheroid models, these works were focused on the development...
3.
Dubois C, Daumar P, Aubel C, Gauthier J, Vidalinc B, Mounetou E, et al.
J Clin Med
. 2019 Mar;
8(3).
PMID: 30901969
Triple-negative breast cancers are particularly aggressive. In vitro cultures are one of the major pathways for developing anticancer strategies. The effectiveness and reproducibility of the drug screenings depend largely on...